PAI-1 protein is encoded by the SERPINE 1 gene in humans. Anopheles mosquitoes have been genetically modified to express PAI-1, which blocks the entry of the malarial Plasmodium into the mosquito gut. This disrupts the Plasmodium life cycle, resulting in reduced transmission of malaria.
- Describe a process that could be used to produce mosquitoes which express PAI-1. (4 marks)
--- 11 WORK AREA LINES (style=lined) ---
- 'Genetic technologies are beneficial for society.'
- Evaluate this statement. (7 marks)
--- 24 WORK AREA LINES (style=lined) ---
a. Mosquito Production
- The SERPINE 1 gene is isolated from human DNA using restriction enzymes that cut at specific recognition sites.
- The same restriction enzymes are used to cut mosquito DNA, creating complementary sticky ends.
- The human PAI-1 gene is inserted into the mosquito DNA using DNA ligase to form recombinant DNA.
- The recombinant DNA is introduced into mosquito eggs or embryos using a vector or microinjection technique.
- Modified mosquitoes are screened to confirm PAI-1 gene expression and successful integration into the genome.
- Transgenic mosquitoes produce PAI-1 protein that blocks Plasmodium entry into the gut, disrupting malaria transmission.
b. Evaluation Statement
Genetic technologies are highly beneficial for society when evaluated against health improvements and food security criteria. Despite some ethical and environmental concerns requiring careful management, the overall benefits are substantial.
Health Benefits
Evidence supporting includes:
- Genetically modified mosquitoes expressing PAI-1 significantly reduce malaria transmission, potentially saving millions of lives annually.
- Recombinant DNA technology produces insulin and vaccines, improving accessibility to life-saving treatments for diabetes and infectious diseases.
- Gene therapy offers potential cures for inherited genetic disorders, dramatically improving quality of life for affected individuals.
The health criterion strongly meets beneficial status because these technologies address major global health challenges.
Food Security and Agricultural Benefits
Evidence supporting includes:
- Genetically modified crops like Bt cotton and Golden Rice increase crop yields and nutritional content, addressing food scarcity.
- Drought-resistant GM crops enable farming in challenging environments, supporting population growth and farmer livelihoods.
However, concerns exist about reduced genetic diversity and corporate control over seeds, creating inequalities in access.
Final Evaluation
Weighing these factors shows genetic technologies are substantially beneficial for society. The health improvements and food security gains outweigh the manageable ethical concerns. While challenges like biodiversity impacts and equitable access require ongoing attention, the overall societal benefit remains considerable through life-saving medical applications and enhanced food production.
a. Mosquito Production
- The SERPINE 1 gene is isolated from human DNA using restriction enzymes that cut at specific recognition sites.
- The same restriction enzymes are used to cut mosquito DNA, creating complementary sticky ends.
- The human PAI-1 gene is inserted into the mosquito DNA using DNA ligase to form recombinant DNA.
- The recombinant DNA is introduced into mosquito eggs or embryos using a vector or microinjection technique.
- Modified mosquitoes are screened to confirm PAI-1 gene expression and successful integration into the genome.
- Transgenic mosquitoes produce PAI-1 protein that blocks Plasmodium entry into the gut, disrupting malaria transmission.
b. Evaluation Statement
Genetic technologies are highly beneficial for society when evaluated against health improvements and food security criteria. Despite some ethical and environmental concerns requiring careful management, the overall benefits are substantial.
Health Benefits
Evidence supporting includes:
- Genetically modified mosquitoes expressing PAI-1 significantly reduce malaria transmission, potentially saving millions of lives annually.
- Recombinant DNA technology produces insulin and vaccines, improving accessibility to life-saving treatments for diabetes and infectious diseases.
- Gene therapy offers potential cures for inherited genetic disorders, dramatically improving quality of life for affected individuals.
The health criterion strongly meets beneficial status because these technologies address major global health challenges.
Food Security and Agricultural Benefits
Evidence supporting includes:
- Genetically modified crops like Bt cotton and Golden Rice increase crop yields and nutritional content, addressing food scarcity.
- Drought-resistant GM crops enable farming in challenging environments, supporting population growth and farmer livelihoods.
However, concerns exist about reduced genetic diversity and corporate control over seeds, creating inequalities in access.
Final Evaluation
Weighing these factors shows genetic technologies are substantially beneficial for society. The health improvements and food security gains outweigh the manageable ethical concerns. While challenges like biodiversity impacts and equitable access require ongoing attention, the overall societal benefit remains considerable through life-saving medical applications and enhanced food production.